Search research articles
Contact Us
Filters
Showing results (21-30 of 198) with videos related to
Page
of 20
Sort By:
Pathology
|
September 2, 2011
Overcoming blocks in apoptosis with BH3-mimetic therapy in haematological malignancies
Seong Lin Khaw, David C S Huang, Andrew W Roberts
Leukemia & Lymphoma
|
June 27, 2009
BH3-mimetics--the solution to chemoresistance?
Seong L Khaw, David C S Huang, Andrew W Roberts
Leukemia & Lymphoma
|
January 24, 2013
BH3 mimetic therapy: an emerging and promising approach to treating chronic lymphocytic leukemia
Mary Ann Anderson, David C S Huang, Andrew W Roberts
Pain Medicine (Malden, Mass.)
|
October 8, 2014
Racial disparities across provider specialties in opioid prescriptions dispensed to medicaid beneficiaries with chronic noncancer pain
Chris Ringwalt, Andrew W Roberts, Hallam Gugelmann, et al.
Leukemia & Lymphoma
|
November 20, 2014
BCL2 inhibition in double hit lymphoma
Mary Ann Anderson, David C S Huang, Andrew W Roberts
Blood
|
July 28, 2021
BCL2 and MCL1 inhibitors for hematologic malignancies
Andrew W Roberts, Andrew H Wei, David C S Huang
Kansas Journal of Medicine
|
September 20, 2021
Reimbursement Policies for Diabetes Prevention Program (DPP): Implications for Racial and Ethnic Health Disparities
Taynara Formagini, Joanna V Brooks, Lisette T Jacobson, et al.
Drug and Alcohol Dependence
|
December 14, 2020
Medicaid prescription limits and their implications for naloxone accessibility
Andrew W Roberts, Kevin A Look, Grace Trull, et al.
Research in Social & Administrative Pharmacy : RSAP
|
September 5, 2021
Trajectories of glycemic control with clinical pharmacy specialist management of veterans with type 2 diabetes
Ted R Grabarczyk, Andrew W Roberts, Jonathan D Mahnken, et al.
Research in Social & Administrative Pharmacy : RSAP
|
April 14, 2018
Reviewing state-mandated training requirements for naloxone-dispensing pharmacists
Andrew W Roberts, Delesha M Carpenter, Austin Smith, et al.
Page
of 20
Search research articles
Search
Showing results (21-30 of 198) with videos related to
Sort By:
Page
of 20
Pathology
|
September 2, 2011
Overcoming blocks in apoptosis with BH3-mimetic therapy in haematological malignancies
Seong Lin Khaw, David C S Huang, Andrew W Roberts
Leukemia & Lymphoma
|
June 27, 2009
BH3-mimetics--the solution to chemoresistance?
Seong L Khaw, David C S Huang, Andrew W Roberts
Leukemia & Lymphoma
|
January 24, 2013
BH3 mimetic therapy: an emerging and promising approach to treating chronic lymphocytic leukemia
Mary Ann Anderson, David C S Huang, Andrew W Roberts
Pain Medicine (Malden, Mass.)
|
October 8, 2014
Racial disparities across provider specialties in opioid prescriptions dispensed to medicaid beneficiaries with chronic noncancer pain
Chris Ringwalt, Andrew W Roberts, Hallam Gugelmann, et al.
Leukemia & Lymphoma
|
November 20, 2014
BCL2 inhibition in double hit lymphoma
Mary Ann Anderson, David C S Huang, Andrew W Roberts
Blood
|
July 28, 2021
BCL2 and MCL1 inhibitors for hematologic malignancies
Andrew W Roberts, Andrew H Wei, David C S Huang
Kansas Journal of Medicine
|
September 20, 2021
Reimbursement Policies for Diabetes Prevention Program (DPP): Implications for Racial and Ethnic Health Disparities
Taynara Formagini, Joanna V Brooks, Lisette T Jacobson, et al.
Drug and Alcohol Dependence
|
December 14, 2020
Medicaid prescription limits and their implications for naloxone accessibility
Andrew W Roberts, Kevin A Look, Grace Trull, et al.
Research in Social & Administrative Pharmacy : RSAP
|
September 5, 2021
Trajectories of glycemic control with clinical pharmacy specialist management of veterans with type 2 diabetes
Ted R Grabarczyk, Andrew W Roberts, Jonathan D Mahnken, et al.
Research in Social & Administrative Pharmacy : RSAP
|
April 14, 2018
Reviewing state-mandated training requirements for naloxone-dispensing pharmacists
Andrew W Roberts, Delesha M Carpenter, Austin Smith, et al.
Page
of 20